Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 3,749	$ 1,338
Accounts receivable, net of allowance of $638 and $587, respectively	149,019	124,069
Inventory	84,366	81,761
Other current assets	7,547	5,989
Total current assets	244,681	213,157
Property, plant and equipment, net	3,261,026	2,301,982
Operating lease right-of-use assets	15,222	14,097
Goodwill	116,937
Intangible assets, net	78,197	30,182
Contract costs, net	35,938	37,739
Deferred tax assets	2,138	3,192
Other assets	54,241	47,733
Non-current assets of discontinued operations	7,868	7,868
Total assets	3,816,248	2,655,950
Current liabilities:
Accounts payable, trade	70,120	61,026
Accrued liabilities	119,303	85,381
Deferred revenue	5,238	5,736
Total current liabilities	194,661	152,143
Long-term debt	2,236,131	1,584,869
Operating lease liabilities	12,536	12,271
Deferred tax liabilities	41,394	4,921
Other liabilities	32,922	22,857
Non-current liabilities of discontinued operations	7,868	7,868
Total liabilities	2,525,512	1,784,929
Commitments and contingencies (Note 8)
Equity:
Preferred stock: $0.01 par value per share, 50,000,000 shares authorized, zero issued
Common stock: $0.01 par value per share, 250,000,000 shares authorized, 185,333,786 and 164,984,401 shares issued, respectively	1,854	1,650
Additional paid-in capital	3,877,203	3,470,576
Accumulated deficit	(2,467,142)	(2,499,931)
Treasury stock: 10,158,142 and 9,020,454 common shares, at cost, respectively	(121,179)	(101,274)
Total equity	1,290,736	871,021
Total liabilities and equity	$ 3,816,248	$ 2,655,950